0      0

2021 AABB Annual Meeting On-Demand

AM21-53: Future Trends in Cell & Gene Therapy: Developments in the Field of Personalized Medicine


Oct 19, 2021 9:00pm ‐ Oct 19, 2021 10:00pm



Credits: None available.

Members: $20.00
Standard: $25.00

Description

This session will focus on future trends in the field of Cell and Gene Therapy and Personalized Medicine. Some of the topics to be discussed include cell therapies, genetically engineered cells, and gene editing technology. Where do we see an increase in Cell & Gene Therapy and what clinical indications? What is developing in the field of personalized medicine that will bring on improvements in Healthcare and how will these improvements affect Healthcare economics? Even with the high cost of these therapies we may see a benefit financially. This session will consist of innovators in the field of Cell and Gene Therapy. Besides short presentations it will include a lively debate as to where the field is headed.


To view Spanish or English subtitles, click the "CC" box in the video player.
Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.


Learning Objectives:
  • Describe new technology seen in Cell and Gene Therapy and Personalized Medicine
  • Discuss Product Development challenges in the field of Cell and Gene Therapy
  • Evaluate of Healthcare Economics of Cell and Gene Therapy

Moderator(s):

Speaker(s):

Disclosures

  • Bruce Levine, PhD : Consultant: Terumo; Scientific Advisory Board: Akron, Avectas, Immuneel, Immusoft, In8bio, Ori Biotech, Vycellix; Co-Founder and equity holder: Tmunity Therapeutics; Royalties: University of Pennsylvania/Novartis; Field of cell and gene therapy: Declaration of financial interest due to intellectual property and patents
  • Julie Allickson, PhD : Nothing to Disclose
  • Anthony Windebank, MD : Scientific Advisory Board: AxoMax

Credits Available


AM21-53: Future Trends in Cell & Gene Therapy: Developments in the Field of Personalized Medicine Evaluation

You must be logged in and own this session in order to post comments.